GB0207434D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0207434D0
GB0207434D0 GB0207434A GB0207434A GB0207434D0 GB 0207434 D0 GB0207434 D0 GB 0207434D0 GB 0207434 A GB0207434 A GB 0207434A GB 0207434 A GB0207434 A GB 0207434A GB 0207434 D0 GB0207434 D0 GB 0207434D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0207434A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0207434A priority Critical patent/GB0207434D0/en
Publication of GB0207434D0 publication Critical patent/GB0207434D0/en
Priority to TW092106766A priority patent/TW200400035A/en
Priority to US10/509,162 priority patent/US7622464B2/en
Priority to JP2003580326A priority patent/JP4465195B2/en
Priority to BR0308780-8A priority patent/BR0308780A/en
Priority to CNA038115506A priority patent/CN1656092A/en
Priority to ES03745294T priority patent/ES2315519T3/en
Priority to PT03745294T priority patent/PT1487828E/en
Priority to RU2004127928/04A priority patent/RU2004127928A/en
Priority to EP03745294A priority patent/EP1487828B1/en
Priority to DE60324535T priority patent/DE60324535D1/en
Priority to SI200331471T priority patent/SI1487828T1/en
Priority to AU2003226757A priority patent/AU2003226757A1/en
Priority to AT03745294T priority patent/ATE413399T1/en
Priority to MXPA04009459A priority patent/MXPA04009459A/en
Priority to DK03745294T priority patent/DK1487828T3/en
Priority to PCT/EP2003/003335 priority patent/WO2003082861A2/en
Priority to CA002480106A priority patent/CA2480106A1/en
Priority to IL16404703A priority patent/IL164047A0/en
Priority to KR10-2004-7015398A priority patent/KR20040093488A/en
Priority to AR20030101081A priority patent/AR040403A1/en
Priority to IS7444A priority patent/IS7444A/en
Priority to NO20044448A priority patent/NO20044448L/en
Priority to CY20081101474T priority patent/CY1108652T1/en
Ceased legal-status Critical Current

Links

GB0207434A 2002-03-28 2002-03-28 Novel compounds Ceased GB0207434D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GB0207434A GB0207434D0 (en) 2002-03-28 2002-03-28 Novel compounds
TW092106766A TW200400035A (en) 2002-03-28 2003-03-26 Novel compounds
AR20030101081A AR040403A1 (en) 2002-03-28 2003-03-27 CCR3 ANTAGONIST MORPHOLINE DERIVATIVES
DE60324535T DE60324535D1 (en) 2002-03-28 2003-03-27 MORPHOLINYL UREA DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DEFENSIVE PROCESSES
AT03745294T ATE413399T1 (en) 2002-03-28 2003-03-27 MORPHOLINYL UREA DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH INFLAMMATORY PROCESSES
BR0308780-8A BR0308780A (en) 2002-03-28 2003-03-27 Compound, process for the preparation and use thereof, method for treating a human or animal subject suffering from, or susceptible to, an inflammatory condition, and, pharmaceutical composition.
CNA038115506A CN1656092A (en) 2002-03-28 2003-03-27 Robertson Graeme Michael et al.
ES03745294T ES2315519T3 (en) 2002-03-28 2003-03-27 MORFOLINILUREA DERIVATIVES FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES.
PT03745294T PT1487828E (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
RU2004127928/04A RU2004127928A (en) 2002-03-28 2003-03-27 MORPHOLINYL UREA DERIVATIVES FOR USE IN TREATMENT OF INFLAMMATORY DISEASES
EP03745294A EP1487828B1 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
US10/509,162 US7622464B2 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
SI200331471T SI1487828T1 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
AU2003226757A AU2003226757A1 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
JP2003580326A JP4465195B2 (en) 2002-03-28 2003-03-27 New compounds
MXPA04009459A MXPA04009459A (en) 2002-03-28 2003-03-27 Novel compounds.
DK03745294T DK1487828T3 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
PCT/EP2003/003335 WO2003082861A2 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
CA002480106A CA2480106A1 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
IL16404703A IL164047A0 (en) 2002-03-28 2003-03-27 Novel compounds
KR10-2004-7015398A KR20040093488A (en) 2002-03-28 2003-03-27 Novel compounds
IS7444A IS7444A (en) 2002-03-28 2004-09-13 Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
NO20044448A NO20044448L (en) 2002-03-28 2004-10-19 New connections
CY20081101474T CY1108652T1 (en) 2002-03-28 2008-12-19 MORPHOLINYL-URINE PRODUCTS FOR USE IN THE INFECTION OF INFECTIOUS DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0207434A GB0207434D0 (en) 2002-03-28 2002-03-28 Novel compounds

Publications (1)

Publication Number Publication Date
GB0207434D0 true GB0207434D0 (en) 2002-05-08

Family

ID=9933986

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0207434A Ceased GB0207434D0 (en) 2002-03-28 2002-03-28 Novel compounds

Country Status (1)

Country Link
GB (1) GB0207434D0 (en)

Similar Documents

Publication Publication Date Title
GB0202216D0 (en) Novel compounds
GB0205256D0 (en) Novel compounds
GB0202679D0 (en) Novel compounds
GB0206723D0 (en) Novel compounds
GB0207249D0 (en) Novel compounds
GB0207246D0 (en) Novel compounds
GB0203299D0 (en) Novel compounds
GB0200025D0 (en) Novel compounds
GB0204252D0 (en) Novel compounds
GB0203437D0 (en) Novel compounds
GB0204255D0 (en) Novel compounds
GB0201231D0 (en) Novel compounds
GB0201357D0 (en) Novel compounds
GB0202140D0 (en) Novel compounds
GB0202141D0 (en) Novel compounds
GB0202217D0 (en) Novel compounds
GB0202219D0 (en) Novel compounds
GB0202442D0 (en) Novel compounds
GB0202636D0 (en) Novel compounds
GB0202637D0 (en) Novel compounds
GB0203300D0 (en) Novel compounds
GB0203301D0 (en) Novel compounds
GB0203363D0 (en) Novel compounds
GB0203369D0 (en) Novel compounds
GB0200787D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)